MedPath

Sucraid

Sucraid (sacrosidase) Oral Solution:

Approved
Approval ID

d613bb7f-c3f4-462e-81a2-da2347cc4b6b

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 15, 2023

Manufacturers
FDA

QOL Medical, LLC

DUNS: 140026258

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

sacrosidase

PRODUCT DETAILS

NDC Product Code67871-111
Application NumberBLA020772
Marketing CategoryC73585
Route of AdministrationORAL
Effective DateDecember 15, 2023
Generic Namesacrosidase

INGREDIENTS (5)

SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
SACROSIDASEActive
Quantity: 8500 [iU] in 1 mL
Code: 8A7F670F2Y
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSL
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sucraid - FDA Drug Approval Details